Faiz Ahmad Khan, MD, MPH
tuberculosis
global health
indigenous health
HIV and tuberculosis
Multi-drug-resistant tuberculosis (MDR-TB)
RESP | Translational Research in Respiratory Diseases Program
Our Researchers
The RESP Program is made up of basic, clinical, population health and outcomes researchers in both adult and pediatric medicine. The program will draw upon the broad expertise of scientists from the Meakins-Christie Laboratories (a centre for fundamental research into the pathophysiology of pulmonary diseases), the Respiratory Epidemiology and Clinical Research Unit (RECRU: a centre for epidemiological research, clinical trials, and economic analyses), as well as scientists from the Montreal Children's Hospital of the McGill University Health Centre (MUHC), the Montreal Chest Institute of the MUHC, and other collaborating institutes.
Filters
Displaying 44 result(s).
|
CORE |
|
Deborah Assayag, MD, MASInterstitial lung diseases pulmonary fibrosis autoimmunity epidemiology prognosis CORE |
|
CTB |
|
Carolyn Baglole, PhDchronic obstructive pulmonary disease toxicology cigarette smoke inflammation lungs CTB |
|
Andrea Benedetti, PhDbiostatistics epidemiology tuberculosis chronic obstructive pulmonary disease (COPD) individual patient data meta analysis CORE |
|
Jean Bourbeau, MD, M.Sc., FRCPCepidemiology outcomes research observational study COPD integrated care and self-management CORE |
|
Robert Brouillette, MDSleep apnea airway obstruction control of breathing tonsils adenoids CIM |
|
|
Karen Brown, MDAnesthesia pediatrics respiration apnea obstructive sleep apnea CIM |
|
Maziar Divangahi, PhDinnate and adaptive immunity influenza virus mycobacterium tuberculosis Coronavirus CTB |
|
Elizabeth Fixman, PhDallergic airways disease type 2 inflammation group 2 innate lymphoid cells cell penetrating peptides animal models CTB |
|
|
Gregory Fonseca, PhDmachine learning transcriptomics epigenomics alveolar macrophages CTB |
|
|
Peter Goldberg, MDAcute lung injury sevrage muscles respiratoires oxyde nitrique CIM |
|
Anne Gonzalez, MD, M.Sc.Lung cancer diagnosis and staging interventional pulmonary procedures CORE |
|
|
Qutayba Hamid, MD, PhD, FRCP, FRS, FRCPathasthma chronic obstructive pulmonary disease remodeling cytokines inflammation CTB |
|
|
John Hanrahan, PhDCFTR chloride secretion cystic fibrosis electrophysiology epithelial transport |
|
|
Sabah Hussain, MD, PhDendothelial cells angiogenesis skeletal muscle atrophy CTB |
|
Dennis Jensen, PhDexercise chronic obstructive pulmonary disease (COPD) respiratory dyspnea therapy CIM |
|
Marta Kaminska, B.Sc., MD, M.Sc.sleep-disordered breathing fatigue cognition neurological disorders noninvasive ventilation CORE |
|
Richard Kimoff, MDSleep apnea upper airway neuromuscular clinical outcomes cardiometabolic CORE |
|
Irah King, PhDInfectious disease barrier tissue immunity gut-lung axis leukocyte migration microbiome CTB |
|
Arnold Kristof, MDCM, FRCPCmTOR nutrition acute lung injury tuberous sclerosis complex lymphangioleiomyomatosis CTB |
|
|
Jennifer Landry, MD, M.Sc.preterm birth bronchopulmonary dysplasia cystic fibrosis lymphangioleiomyomatosis tuberous sclerosis CIM |
|
Larry Lands, MD, PhDCystic fibrosis (CF) asthma immune modulation physical activity translational research CTB |
|
Anne-Marie Lauzon, PhDasthma smooth muscle biophysics myosin actin CTB |
|
James Martin, MDasthma immunology cysteinyl leukotrienes airway remodeling epidermal growth factor receptor CTB |
|
|
CIM |
|
Bruce Mazer, MDAsthma food allergy immune therapies intravenous immunoglobulin B-lymphocytes and mucosal responses CTB |
|
Christine McCusker, MD, M.Sc.allergy developmental immunology asthma immunomodulation CTB |
|
Dick Menzies, MDtuberculosis biostatistics epidemiology respiratory disease global health CORE |
|
Dao Nguyen, MD, MScMicrobiology cystic fibrosis Pseudomonas aeruginosa host-pathogen interactions antibiotic tolerance CTB |
|
Ronald Olivenstein, MDasthma bronchoscopy chronic obstructive pulmonary disease (COPD) cytokines inflammation CIM |
|
Sushmita Pamidi, MDsleep apnea pregnancy cardiometabolic consequences biomarkers CORE |
|
Basil Petrof, MDdiaphragm muscular dystrophy ICU-acquired muscle weakness sepsis neuromuscular respiratory failure CTB |
|
|
Pramod Puligandla, MD, M.Sc.health services surgical outcomes surgically correctable congenital anomalies congenital diaphragmatic hernia pediatric surgical critical care CIM |
|
|
Salman Qureshi, MDfungal infection pneumonia sepsis forward genetic analysis innate immunity CTB |
|
Simon Rousseau, PhDcystic fibrosis bacterial infections signal transduction protein phosphorylation inflammation CTB |
|
Guilherme Sant'Anna, MD, PhDneonatal invasive and non-invasive ventilation hypoxic-ischemic encephalopathy heart rate variability CORE |
|
Kevin Schwartzman, MD MPHtuberculosis epidemiology public health respiratory disease health economics CORE |
|
|
Jason Shahin, MDcritical care prediction tool chronic critically ill organ donor prolonged mechanical ventilation CORE |
|
Benjamin Smith, MD, M.Sc., FRCPCobstructive lung diseases imaging cardiopulmonary physiology CORE |